Global Newsroom

^{_{CSL Behring Patient Zahra Khan, living with hereditary angioedema}}

Global Newsroom

How Can We Help You?

Media Resources
Media Contacts

Recent News Releases

Featuring releases from CSL, CSL Behring, CSL Seqirus and CSL Vifor.

Email Alerts

Oct 24, 2024

Investigations into lung cancer and into epigenetics recognised with 2 x $1.25 million CSL Centenary Fellowships

MELBOURNE – 24 October 2024 – Two scientists have each been awarded CSL Centenary Fellowships, valued at $1.25 million over five years. They are developing...

Recent News Releases

Email Alerts

CSL Behring

Jan 16, 2024

Harris Poll Survey Finds People Receiving Treatment for CIDP Are Interested in Exploring More Convenient Treatment Options

Findings show that convenience of treatment and flexibility of administration, such as at-home treatment options, are of high importance to patients KING OF PRUSSIA, Pa., Jan. 16, 2024...

Recent News Releases

Email Alerts

CSL Seqirus

Sep 26, 2024

OPTIONS XII IS COMING HOME

As we approach the OPTIONS XII for the Control of Influenza, a global scientific meeting that focuses on influenza, there is an enormous sense of pride among all of us at CSL Seqirus. For the...

Recent News Releases

Email Alerts

CSL Vifor

Oct 17, 2024

CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the treatment of IgA Nephropathy

Temporary marketing authorization is based on statistically significant and clinically meaningful results from the phase-III PROTECT trial ST. GALLEN, Switzerland and SAN DIEGO, Oct. 17, 2024...